Samsung Asset Management (New York)’s Biogen BIIB Stock Holding History

Samsung Asset Management (New York)’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$4.07M	Sell	12,990 -2,890	-18%	-$856K	3.72%	4
2016 Q2	$3.84M	Sell	15,880 -11,820	-43%	-$3.12M	2.98%	7
2016 Q1	$7.21M	Buy	27,700 +2,720	+11%	+$718K	3.26%	6
2015 Q4	$7.65M	Sell	24,980 -3,630	-13%	-$1.04M	3.06%	6
2015 Q3	$8.35M	Buy	28,610 +12,720	+80%	+$4.2M	3.21%	8
2015 Q2	$6.42M	Buy	15,890 +4,080	+35%	+$1.64M	2.16%	11
2015 Q1	$4.99M	Buy	+11,810	New	+$4.65M	1.66%	22

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Samsung Asset Management (New York)'s BIIB Position: Q3 2016 in Review

Samsung Asset Management (New York) reduced its Biogen (BIIB) stake by 18% in Q3 2016, selling an estimated $856K and leaving 12,990 shares worth $4.07M. The position accounts for 3.72% of the portfolio, ranked #4.

Samsung Asset Management (New York) first reported a position in BIIB in Q1 2015 and has held it in 7 quarters since. The position peaked at $8.35M in Q3 2015. 1,013 funds tracked by Wall St. Rank hold BIIB as of Q3 2016.

Samsung Asset Management (New York) held 12,990 shares of Biogen worth $4.07M as of Q3 2016.
Samsung Asset Management (New York) sold 2,890 Biogen shares in Q3 2016, an estimated $856K.
Biogen made up 3.72% of Samsung Asset Management (New York)'s portfolio in Q3 2016, its #4 holding.
Samsung Asset Management (New York) first reported a position in Biogen in Q1 2015 and has held it in 7 quarters since.
Samsung Asset Management (New York)'s Biogen position peaked at $8.35M in Q3 2015.
1,013 funds tracked by Wall St. Rank held Biogen as of Q3 2016.

Based on Samsung Asset Management (New York)'s 13F filing for Q3 2016, filed 10 Nov 2016.